117 related articles for article (PubMed ID: 34558771)
1. A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma.
Berg M; Adnan A; Högmo A; Sjödin H; Gebre-Medhin M; Laurell G; Reizenstein J; Farnebo L; Norberg LS; Notstam I; Holmberg E; Cange HH; Hammerlid E;
Head Neck; 2021 Dec; 43(12):3843-3856. PubMed ID: 34558771
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life among tonsillar carcinoma patients in Sweden in relation to treatment and comparison with quality of life among the population.
Adnan A; Högmo A; Sjödin H; Gebre-Medhin M; Laurell G; Reizenstein J; Farnebo L; Norberg LS; Notstam I; Holmberg E; Cange HH; Hammerlid E;
Head Neck; 2020 May; 42(5):860-872. PubMed ID: 32040223
[TBL] [Abstract][Full Text] [Related]
3. The effect of age on health-related quality of life for head and neck cancer patients up to 1 year after curative treatment.
Berg M; Silander E; Bove M; Johansson L; Nyman J; Hammerlid E
J Geriatr Oncol; 2022 Jan; 13(1):60-66. PubMed ID: 34244112
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer.
Nordfors C; Vlastos A; Du J; Ahrlund-Richter A; Tertipis N; Grün N; Romanitan M; Haeggblom L; Roosaar A; Dahllöf G; Donà MG; Benevolo M; Ramqvist T; Munck-Wikland E; Dalianis T
Oral Oncol; 2014 May; 50(5):491-7. PubMed ID: 24613649
[TBL] [Abstract][Full Text] [Related]
5. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival.
Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):207-217. PubMed ID: 29159750
[TBL] [Abstract][Full Text] [Related]
6. HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer.
Tertipis N; Villabona L; Nordfors C; Näsman A; Ramqvist T; Vlastos A; Masucci G; Dalianis T
Anticancer Res; 2014 May; 34(5):2369-75. PubMed ID: 24778045
[TBL] [Abstract][Full Text] [Related]
7. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study.
Verdonck-de Leeuw IM; Buffart LM; Heymans MW; Rietveld DH; Doornaert P; de Bree R; Buter J; Aaronson NK; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2014 Mar; 110(3):422-8. PubMed ID: 24582144
[TBL] [Abstract][Full Text] [Related]
8. Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011.
Platek ME; Jayaprakash V; Gupta V; Cohan DM; Hicks WL; Winslow TB; Platek AJ; Groman A; Dibaj S; Arshad H; Kuriakose MA; Warren GW; Singh AK
Laryngoscope; 2017 May; 127(5):1087-1092. PubMed ID: 27808409
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
Näsman A; Bersani C; Lindquist D; Du J; Ramqvist T; Dalianis T
Anticancer Res; 2017 Oct; 37(10):5319-5328. PubMed ID: 28982840
[TBL] [Abstract][Full Text] [Related]
10. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
[TBL] [Abstract][Full Text] [Related]
11. Quality of life after different treatment modalities for carcinoma of the oropharynx.
Tschudi D; Stoeckli S; Schmid S
Laryngoscope; 2003 Nov; 113(11):1949-54. PubMed ID: 14603054
[TBL] [Abstract][Full Text] [Related]
12. Assessing quality of life in patients with head and neck cancer in Spain by means of EORTC QLQ-C30 and QLQ-H&N35.
López-Jornet P; Camacho-Alonso F; López-Tortosa J; Palazon Tovar T; Rodríguez-Gonzales MA
J Craniomaxillofac Surg; 2012 Oct; 40(7):614-20. PubMed ID: 22425499
[TBL] [Abstract][Full Text] [Related]
13. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
[TBL] [Abstract][Full Text] [Related]
15. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
[TBL] [Abstract][Full Text] [Related]
16. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study.
Borggreven PA; Verdonck-de Leeuw IM; Muller MJ; Heiligers ML; de Bree R; Aaronson NK; Leemans CR
Eur Arch Otorhinolaryngol; 2007 Jun; 264(6):651-7. PubMed ID: 17273840
[TBL] [Abstract][Full Text] [Related]
18. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
[TBL] [Abstract][Full Text] [Related]
19. Population-based reference values for the European Organization for Research and Treatment of Cancer Head and Neck module.
Hammerlid E; Adnan A; Silander E
Head Neck; 2017 Oct; 39(10):2036-2047. PubMed ID: 28708279
[TBL] [Abstract][Full Text] [Related]
20. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?
Näsman A; Nordfors C; Holzhauser S; Vlastos A; Tertipis N; Hammar U; Hammarstedt-Nordenvall L; Marklund L; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
Eur J Cancer; 2015 Jan; 51(1):55-61. PubMed ID: 25466506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
